Fate Therapeutics, Boston Children's Hospital, Massachusetts General Hospital deal

Fate received an exclusive license to IP co-owned by the hospitals covering compositions and methods for supporting hematopoietic stem cells (HSCs). Fate will use the technology to develop its stem ce...